Risk of Cutaneous Squamous Cell Carcinoma in Patients With Hidradenitis Suppurativa Treated With Adalimumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study
J Eur Acad Dermatol Venereol 2024 Feb 26;[EPub Ahead of Print], A Smetanová, M Pásek, E Marques, J Vránová, P Arenberger, A Machovcová, Z Horáčková, M ArenbergerováFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.